NCT04056676

Brief Summary

To compare efficacy and safety of adding thoracic paravertebral nerve blocks to modified PEC block versus modified PEC block only in breast cancer surgery. This study evaluate systemic opioid requirement in 48 hours in primary outcome and the analgesic profile ( pain score at rest and on shoulder movement), opioid-related side effects and nerve blocks complications.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

May 24, 2021

Status Verified

May 1, 2021

Enrollment Period

2.3 years

First QC Date

August 8, 2019

Last Update Submit

May 21, 2021

Conditions

Keywords

Postoperative painThoracic paravertebral blockModified PEC blockBreast cancerTotal mastectomy with sentinel lymph node clearance

Outcome Measures

Primary Outcomes (2)

  • Postoperative fentanyl consumption

    Cumulative fentanyl consumption within postoperative 24 hours

    at postoperative 24 hours

  • Postoperative fentanyl consumption

    Cumulative fentanyl consumption within postoperative 24-48 hours

    at postoperative 48 hours

Secondary Outcomes (17)

  • Intraoperative fentanyl use

    Intraoperation

  • Postoperative pain score at rest

    at postoperative 0 hour (PACU arrival)

  • Postoperative pain score at rest

    at postoperative 30 min (in PACU)

  • Postoperative pain score at rest

    at postoperative 1 hour (in PACU)

  • Postoperative pain score at rest

    Postoperative 6 hour (at ward)

  • +12 more secondary outcomes

Study Arms (2)

Intraoperative modified PEC block only

ACTIVE COMPARATOR

Intraoperative modified PEC block with 0.5% bupivacaine 20 ml plus adrenaline 100 ug by surgeon

Procedure: Intraoperative modified PEC blockProcedure: GA with ETT

Adding preoperative thoracic paravertebral nerve block

EXPERIMENTAL

Preoperative thoracic paravertebral nerve block with 0.5% bupivacaine 20 ml plus adrenaline 100 ug and intraoperative modified PEC block with 0.5% bupivacaine 20 ml plus adrenaline 100 ug by surgeon

Procedure: Thoracic paravertebral block under ultrasound guidanceProcedure: Intraoperative modified PEC blockProcedure: GA with ETT

Interventions

Ultrasound-guided thoracic paravertebral blocks in T2, T4 level

Also known as: USG-TPVB
Adding preoperative thoracic paravertebral nerve block

Pectoral nerve block by surgeon under direct vision after total mastectomy

Also known as: Modified PEC block
Adding preoperative thoracic paravertebral nerve blockIntraoperative modified PEC block only
GA with ETTPROCEDURE

General anesthesia with endotracheal intubation

Adding preoperative thoracic paravertebral nerve blockIntraoperative modified PEC block only

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) grade I-III
  • Aged ≥ 18-80 years old
  • Elective unilateral total mastectomy with sentinel lymph node biopsy or lymph node dissection

You may not qualify if:

  • Patient refusal
  • Language barrier or inability to communicate with the operating team
  • Allergy to local anesthetic
  • Bleeding disorder
  • Previous breast surgery or thoracic radiation therapy
  • BMI ≥ 30
  • Patient who can not understand the proper use of intravenous patient-controlled analgesia machine or who has the problem with communication
  • Chronic pain patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok Noi, Bangkok, 10700, Thailand

RECRUITING

Related Publications (7)

  • Missair A, Cata JP, Votta-Velis G, Johnson M, Borgeat A, Tiouririne M, Gottumukkala V, Buggy D, Vallejo R, Marrero EB, Sessler D, Huntoon MA, Andres J, Casasola OL. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article. Reg Anesth Pain Med. 2019 Jan;44(1):13-28. doi: 10.1136/rapm-2018-000001.

    PMID: 30640648BACKGROUND
  • Woodworth GE, Ivie RMJ, Nelson SM, Walker CM, Maniker RB. Perioperative Breast Analgesia: A Qualitative Review of Anatomy and Regional Techniques. Reg Anesth Pain Med. 2017 Sep/Oct;42(5):609-631. doi: 10.1097/AAP.0000000000000641.

    PMID: 28820803BACKGROUND
  • Wynne R, Lui N, Tytler K, Koffsovitz C, Kirwa V, Riedel B, Ryan S. The Trajectory of Postoperative Pain Following Mastectomy with and without Paravertebral Block. Pain Manag Nurs. 2017 Aug;18(4):234-242. doi: 10.1016/j.pmn.2017.03.003. Epub 2017 Jun 7.

    PMID: 28601480BACKGROUND
  • Syal K, Chandel A. Comparison of the post-operative analgesic effect of paravertebral block, pectoral nerve block and local infiltration in patients undergoing modified radical mastectomy: A randomised double-blind trial. Indian J Anaesth. 2017 Aug;61(8):643-648. doi: 10.4103/ija.IJA_81_17.

    PMID: 28890559BACKGROUND
  • Terkawi AS, Tsang S, Sessler DI, Terkawi RS, Nunemaker MS, Durieux ME, Shilling A. Improving Analgesic Efficacy and Safety of Thoracic Paravertebral Block for Breast Surgery: A Mixed-Effects Meta-Analysis. Pain Physician. 2015 Sep-Oct;18(5):E757-80.

    PMID: 26431130BACKGROUND
  • Klein SM, Bergh A, Steele SM, Georgiade GS, Greengrass RA. Thoracic paravertebral block for breast surgery. Anesth Analg. 2000 Jun;90(6):1402-5. doi: 10.1097/00000539-200006000-00026.

    PMID: 10825328BACKGROUND
  • Bashandy GM, Abbas DN. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):68-74. doi: 10.1097/AAP.0000000000000163.

    PMID: 25376971BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeBreast Neoplasms

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Suwimon Tangwiwat, MD

    Mahidol University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Suwimon Tangwiwat, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Randomized group of patient is identified and sealed in envelope. There is not written group in anesthetic record. Postoperative outcomes are assessed by Acute Pain Service nurse or a resident (co-investigator who blinds to the technique).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: group A Intraoperative modified PEC block only group B Preoperative thoracic paravertebral block plus intraoperative modified PEC block
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor, Department of Anesthesiology

Study Record Dates

First Submitted

August 8, 2019

First Posted

August 14, 2019

Study Start

August 1, 2019

Primary Completion

December 1, 2021

Study Completion

March 1, 2022

Last Updated

May 24, 2021

Record last verified: 2021-05

Locations